Financhill
Back

Biolase Stock Predictions

Biolase Stock Forecast

  • Is Biolase Stock Undervalued?
    The current Biolase [BIOLQ] share price is $0.0120. The Score for BIOLQ is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BIOLQ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Biolase Stock Go Up Next Year?

Data Unavailable

Biolase Stock Rating

Data Unavailable

Biolase Stock Price History

Is BIOLQ stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIOLQ is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
biolase.com

52-Week Data

52-Week High:
0.2000
52-Week Low:
0.0040

Prediction Charts

Market Cap:
439.2K
Price in USD:
0.0120
Volume:
32.4K
Beta:
1.5254

Technical Analysis

SMA50:
0.0098
SMA100:
0.0091
SMA200:
0.0283
52-Wk Change:
-91.83%

Stock Predictions

  • Is Biolase stock public?
    Yes, Biolase is a publicly traded company.
  • What is the Biolase stock quote today?
    The Biolase stock price is 0.0120 USD today.
  • How to buy Biolase stock online?
    You can buy Biolase shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-31 0.0077 0.0140 0.0150 0.0077
Apr-1 0.0078 0.0078 0.0078 0.0078
Apr-2 0.0080 0.0080 0.0140 0.0080
Apr-3 0.0080 0.0135 0.0150 0.0080
Apr-4 0.0080 0.0108 0.0120 0.0080
Apr-7 0.0090 0.0120 0.0120 0.0090
Apr-8 0.0118 0.0130 0.0130 0.0090
Apr-9 0.0138 0.0100 0.0144 0.0090
Apr-10 0.0100 0.0100 0.0113 0.0100
Apr-11 0.0144 0.0140 0.0144 0.0120
Apr-14 0.0120 0.0137 0.0140 0.0100
Apr-15 0.0100 0.0121 0.0121 0.0100
Apr-16 0.0142 0.0121 0.0142 0.0100
Apr-17 0.0120 0.0120 0.0142 0.0100

Biolase Earnings

Data Unavailable

Biolase Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and a decrease next year of $0.00 per share.

* Biolase stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.